Nebula Research & Development LLC Amneal Pharmaceuticals, Inc. Transaction History

Nebula Research & Development LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$5.36 - $7.11 $120,605 - $159,982	22,501 Added 23.25%	119,284 $757 Million
Q1 2024 May 15, 2024	BUY	$5.24 - $6.34 $291,286 - $352,434	55,589 Added 134.94%	96,783 $587 Million
Q4 2023 Feb 14, 2024	BUY	$3.36 - $6.21 $94,600 - $174,842	28,155 Added 215.93%	41,194 $250 Million
Q3 2023 Nov 14, 2023	BUY	$2.76 - $4.59 $35,987 - $59,849	13,039 New	13,039 $55 Million

185

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.28B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Nebula Research & Development LLC, based on Form 13F filings with the SEC.

Stay updated on Nebula Research & Development LLC with notifications on news.